
ASND, GDS, ADSK and CDZI among after hours movers
16.3BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
DK0060615755
CUSIP
04351P101
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
19.26
PEG Ratio
-
Book Value
-3.07
Dividend Share
-
Dividend Yield
-
Earnings Share
12.9
Wall Street Target Price
310.06
EPS Estimate Current Year
9.92
EPS Estimate Next Year
8.59
EPS Estimate Current Quarter
-0.148
EPS Estimate Next Quarter
0.5225
Most Recent Quarter
-
Revenue TTM
1,047,020,032
Gross Profit TTM
955,894,976
EBITDA
263,454,000
Profit Margin
70.85%
Return On Assets TTM
9.58%
Return On Equity TTM
118.78%
Revenue Per Share TTM
16.889
Qtly Revenue Growth YOY
114.70%
Diluted Eps TTM
12.9
Qtly Earnings Growth YOY
0.00%
Trailing PE
19.26
Forward PE
15
Price Sales TTM
15.5678
Price Book MRQ
9.8435
Enterprise Value Revenue
13
Enterprise Value EBITDA
72
977.36
12.60%124.42
1.48%811.92
0.70%213.24
0.50%518.06
0.46%364.00
0.42%98.03
0.00%254.59
-3.23%23.95
-0.66%982.36
-0.59%